Stockscreener 앱 받기
17.36
2.69%
-0.48
시간 외 거래:
17.38
0.02
+0.12%
전일 마감가:
$17.84
열려 있는:
$18.05
하루 거래량:
254.52K
Relative Volume:
0.51
시가총액:
$4.74B
수익:
$1.40B
순이익/손실:
$164.00M
주가수익비율:
28.89
EPS:
0.6009
순현금흐름:
$-11.09M
1주 성능:
+2.48%
1개월 성능:
-6.97%
6개월 성능:
-15.93%
1년 성능:
-29.55%
1일 변동 폭
$17.23
$18.19
1주일 범위
$16.50
$18.67
52주 변동 폭
$12.89
$28.00
Stevanato Group Spa Stock (STVN) Company Profile
Compare STVN vs ISRG, BDX, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STVN
Stevanato Group Spa
|
17.36 | 4.87B | 1.40B | 164.00M | -11.09M | 0.6009 |
ISRG
Intuitive Surgical Inc
|
405.97 | 143.33B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
155.19 | 42.96B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
39.61 | 32.87B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.61 | 33.07B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
198.43 | 29.05B | 5.54B | 1.52B | 1.74B | 10.37 |
Stevanato Group Spa Stock (STVN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 재개 | Morgan Stanley | Equal-Weight |
| 2024-12-13 | 개시 | Wolfe Research | Outperform |
| 2024-12-03 | 재개 | Morgan Stanley | Equal-Weight |
| 2024-04-22 | 개시 | Exane BNP Paribas | Outperform |
| 2023-11-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-09-26 | 개시 | Stephens | Overweight |
| 2023-09-19 | 개시 | CJS Securities | Market Outperform |
| 2023-08-24 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-08-10 | 개시 | BofA Securities | Buy |
| 2021-08-10 | 개시 | Citigroup | Buy |
| 2021-08-10 | 개시 | Jefferies | Buy |
| 2021-08-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2021-08-10 | 개시 | Morgan Stanley | Overweight |
| 2021-08-10 | 개시 | Wells Fargo | Overweight |
모두보기
Stevanato Group Spa 주식(STVN)의 최신 뉴스
(STVN) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Enterprise value to revenue forward of Stevanato Group S.p.A. – NYSE:STVN - TradingView
Price to sales forward of Stevanato Group S.p.A. – NYSE:STVN - TradingView
Stevanato Group SpA Actuals & Estimates (NYSE:STVN) - TradingView
Price to book forward of Stevanato Group SpA – LSX:A3CUMB - TradingView
STVN SEC FilingsStevanato Group S P A 10-K, 10-Q, 8-K Forms - Stock Titan
Stevanato Group (STVN) director granted 4,975 shares, sells 1,493 to cover taxes - Stock Titan
[Form 4] Stevanato Group S.p.A. Insider Trading Activity - Stock Titan
Director Sue-Jean Lin granted 4,975 Stevanato Group (STVN) shares as equity pay - Stock Titan
Stevanato (NYSE: STVN) director gets share grant, sells some for taxes - Stock Titan
Luciano Santel receives 4,975 Stevanato (STVN) shares as director pay - Stock Titan
Director Magistretti receives 4,975 Stevanato Group (STVN) shares as equity grant - Stock Titan
Stevanato Group (STVN) officer gains shares through PSUs and RSU awards - Stock Titan
Stevanato Group (STVN) director granted shares, sells portion to cover taxes - Stock Titan
Stevanato Group (STVN) director granted 4,975 shares, sells 1,493 to pay taxes - Stock Titan
Stevanato Group SpA Actuals & Estimates (DUS:87N) - TradingView
STVN Forecast — Price Target — Prediction for 2027 - TradingView
Stevanato Group SpA (STVN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Stevanato Group SpA (STVN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring a 39% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Stevanato Group SpA (STVN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Stevanato Group SpA (STVN) Institutional Confidence - TradingKey
Stevanato Group SpA (STVN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
(STVN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Stevanato Group SpA (STVN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Stevanato Group SpA (STVN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Stevanato Group SpA (STVN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Stevanato Group SpA (STVN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TD Cowen initiates Stevanato stock with buy rating on margin outlook By Investing.com - Investing.com South Africa
TD Cowen initiates Stevanato stock with buy rating on margin outlook - Investing.com
Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring a 42.79% Potential Upside in the Medical Instruments Sector - DirectorsTalk Interviews
Stevanato Group (STVN) Stock Valuation Check After Recent Share Price Weakness - Yahoo Finance
Sustainable Pharmaceutical Packaging Market to Reach USD 270.4 Billion by 2031, Wissen Research - Moomoo
Is Stevanato Group S.p.A. (STVN) A Good Stock To Buy Now? - Insider Monkey
Stevanato: HVS Momentum Overshadows Engineering Weakness, Offering Compelling Upside - Seeking Alpha
Stevanato Group launches pen injector for diabetes drugs By Investing.com - Investing.com Nigeria
2 Dirt Cheap Healthcare Stocks to Buy With $1,000 Right Now - The Motley Fool
Stevanato Group launches Deora pen injector platform targeting GLP-1 and incretin therapies - Manufacturing Chemist
Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneo - GuruFocus
Stevanato Group (STVN) Q1 2026 Earnings: EPS Beats Estimates Amid Quiet Revenue DisclosureShort-Term Outlook - newsline.com
Stevanato Group Launches Deora Pen Injector for Diabetes and Weight Management Therapies - World Business Outlook
Stevanato Group launches pen injector platform targeting GLP-1, obesity drug market - Medical Economics
Stevanato Group Introduces New Proprietary Pen Injector Platform - Contract Pharma
Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management - Stevanato Group S.p.A. (STVN)
Stevanato Group launches pen injector for diabetes drugs - Investing.com UK
Stevanato Group S.p.A. (STVN): Analyst Consensus Highlights 32.12% Potential Upside - DirectorsTalk Interviews
Stevanato Group S.p.A (STVN) Q4 2023 Earnings Call Transcript - MLQ.ai
(STVN) Risk Channels and Responsive Allocation - Stock Traders Daily
Stevanato Group (STVN) Holds Steady Near Support as Market Weighs FundamentalsBollinger Band - newsline.com
Stevanato Group Shareholders Approve 2025 Accounts, Dividend and Governance Changes - The Globe and Mail
[6-K] Stevanato Group S.p.A. Current Report (Foreign Issuer) | STVN SEC FilingForm 6-K - Stock Titan
Stevanato Group Spa (STVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.09%
0.52%
자본화:
|
볼륨(24시간):